BCL3 and rheumatoid arthritis: This cell-type specific effect was corroborated by work in CD4+ cells using a rheumatoid arthritis model, which showed overexpression of Bcl-3 in these cells was implicated in the pathogenesis of rheumatoid arthritis (76).